Drug Profile
DU 125530
Latest Information Update: 10 Jul 2007
Price :
$50
*
At a glance
- Originator Solvay
- Class Antidepressants; Anxiolytics
- Mechanism of Action Serotonin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 20 Jul 2001 Phase-II clinical trials in Depression in Europe (unspecified route)
- 20 Jul 2001 Phase-II clinical trials for Depression (Unknown route)